Chemical industry – Page 67
-
BusinessUS regulator says DuPont’s safety programme ‘failed’
The US Occupational Safety and Health Administration has again proposed to fine DuPont after uncovering ‘repeated’ and ‘serious’ lapses in the company’s worker safety programme
-
Opinion
Taking responsibility seriously
Companies have a duty to be proactive when it comes to sustainability
-
BusinessChemical firms seek better grasp of biomanufacturing
The search is on for better alternatives to the ‘broken’ way companies harness compound-making organisms
-
BusinessAn unsustainable hypocrisy
Social responsibility should extend through the whole supply chain, not just be a tool to put pressure on feedstock suppliers
-
NewsUS chemical industry lobby group in the hot seat again
Union of Concerned Scientists calls for greater transparency in the political activities of American Chemistry Council and member companies
-
Business
US import ban imposed on Indian pharma firm
Concerns over manufacturing processes at Emcure facility prompts Food and Drug Administration to block drug shipments
-
Business
US chemical maker Platform expands with Alent purchase
Platform Specialty Products plans to enlarge its scope and reach by acquiring British chemicals firm Alent for $2.1bn
-
Business
Celgene backs immunotherapy with Juno collaboration
$1bn investment in 10-year CAR-T cell partnership for cancer treatments
-
Business
Thermo Fisher to buy Alfa Aesar chemical supplies
Research chemicals business no longer a strategic fit for owner Johnson Matthey
-
Business
Blast kills six at South Korean chemical plant
One further worker injured as tank explodes during welding work
-
FeaturePharma queues up for checkpoint inhibitor collaborations
Combinations of different firms’ drugs seek to reap immuno-oncology’s benefits
-
Business
Job cuts at Allergan and Transgene
Allergan is shedding 300 staff at former Actavis site in Iceland, while Transgene is closing its French manufacturing plant with loss of 120 jobs
-
Business
Fracking prohibited in New York state and Lancashire
Local US and UK rulings prohibit shale oil drilling and exploration
-
Business
Allergan to buy Kythera Biopharma for $2.1bn
Acquisition strengthens firm’s position in cosmetic treatments with only drug approved for a ‘double chin’
-
OpinionMissing the target
There are plenty of things that small molecule drugs can’t touch, says Derek Lowe, and it’s not for want of trying
-
BusinessSafer substitutes show growth potential
The global market for alternative products based on ‘green’ chemistry is growing fast, fuelled by regulation and consumer demand
-
Business
Alnylam accuses Dicerna of stealing trade secrets
Firm claims rights to GalNAc conjugated siRNA technology acquired from Merck & Co
-
Business
Suspect suicide won’t end trade secret theft probe
An ex-PPG chemist who was arrested for selling trade secrets to a Chinese firm has killed himself, but the Justice Department will continue its investigation
-
BusinessCompanies clamour for CAR-T
Engineered immune cell therapies show promise in early cancer trials, prompting firms to compete for a foothold in the field